NBTX logo

Nanobiotix S.A. American Depositary Shares

NBTX

NBTX: Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. It develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

more

Show NBTX Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of NBTX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by NBTX's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard
Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Coated nanoparticles for use for modulating electrical polarization of neurons Jan. 25, 2022
  • Patent Title: Nanoparticles for use as a therapeutic vaccine Aug. 24, 2021
  • Patent Title: Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer Jun. 01, 2021
  • Patent Title: Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof Mar. 16, 2021
  • Patent Title: Compositions and methods for use in medical diagnosis Mar. 17, 2020
  • Patent Title: Pharmaceutical composition, preparation and uses thereof Sep. 17, 2019
  • Patent Title: Metallic nanoparticles, preparation and uses thereof Aug. 27, 2019
  • Patent Title: Pharmaceutical composition combining at least two distinct nanoparticles and a pharmaceutical compound, preparation and uses thereof Aug. 27, 2019
  • Patent Title: Pharmaceutical composition comprising nanoparticles, preparation and uses thereof Apr. 23, 2019
  • Patent Title: Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer Oct. 16, 2018
  • Patent Title: Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles Sep. 04, 2018
  • Patent Title: Nanoparticles delivery systems, preparation and uses thereof May. 01, 2018
  • Patent Title: Metallic nanoparticles, preparation and uses thereof Jul. 11, 2017
  • Patent Title: Activatable particles, preparation and uses Sep. 06, 2016
  • Patent Title: Activatable particles, preparations and uses Oct. 20, 2015
  • Patent Title: Inorganic nanoparticles of high density to destroy cells in-vivo Sep. 30, 2014
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of NBTX in WallStreetBets Daily Discussion

NBTX News

Recent insights relating to NBTX

CNBC Recommendations

Recent picks made for NBTX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NBTX

Corporate Flights

Flights by private jets registered to NBTX